Pakistan is facing a severe medicine crisis, with over 200 essential drugs unavailable in hospitals and pharmacies, and around 100 of them having no alternative brands. The situation has been exacerbated by local pharmaceutical companies ceasing production due to demands for higher prices from manufacturers and fluctuations in the exchange rate affecting the import of certain medications.
The scarcity of essential medicines spans across various life-threatening conditions, including tuberculosis, blood thinning agents, Parkinson’s disease and epilepsy treatments, medications for mental illnesses, and preventive vaccines for cervical cancer, Hepatitis B and A, human growth hormones, and cataract prevention.
Read more : Punjab Ministers Announce Limitations on Health Card Coverage
The Pakistan Pharmaceutical Manufacturers Association (PPMA) has raised concerns that some local and multinational pharmaceutical companies have halted production due to economic infeasibility, leading patients to resort to smuggled and counterfeit medicines, posing greater health risks.
Drug inspectors in Sindh, Punjab, and Islamabad have also verified the shortage of essential medicines and the growing dependence on smuggled alternatives.
To address the crisis, the Drug Regulatory Authority of Pakistan (DRAP) has submitted a list of 220 medicines as hardship cases to the Ministry of Health, seeking price increases to be considered by the Economic Coordination Committee (ECC) of the federal cabinet. Approval from the ECC could help ensure the availability of these critical medications and safeguard the lives of patients across the country.
In response to the situation, DRAP is taking measures to expedite registrations and facilitate the availability of essential medicines, with some companies expressing interest in importing these medications from countries with lower prices compared to Western pharmaceutical firms.
As the medicine crisis continues to escalate, it is crucial for the government to address the shortages promptly and ensure the availability of critical medications to protect the health and well-being of its citizens.
